Current Report Filing (8-k)
March 25 2016 - 6:14AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported):
March 21, 2016 (March 21, 2016)
PetLife
Pharmaceuticals, Inc.
(Exact name of registrant as specified in its
charter)
Nevada
|
|
000-52445
|
|
33-1133537
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification No.)
|
433
N. Camden Dr., Beverly Hills, CA
|
|
90210
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s telephone number, including
area code: (310) 279-5152
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
[ ] Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Certain Officers or Directors; Election
of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers
On March 21, 2016, the Board of Directors of Petlife Pharmaceuticals,
Inc. (the “Company”) appointed Ralph T. Salvagno, M.D. to its Board of Directors and as the Chairman of the Board of
Directors.
Dr. Salvagno is a Board-Certified Orthopaedic Surgeon practicing
in the Hagerstown, Maryland area. Performing approximately 70% of all joint replacement surgeries in Washington County, Dr. Salvagno
has established himself as the preeminent orthopedic surgeon in the area.
A graduate of the University of Maryland School of Medicine, Dr.
Salvagno completed his residency in orthopedic surgery at Case Western Reserve University in Cleveland, Ohio. He is a member of
the American Academy of Orthopedic Surgeons and the American Association of Hip and Knee Surgeons.
Dr. Salvagno specializes in joint replacements of the hip, knee,
and shoulder. He has practiced orthopedic surgery in Hagerstown since 1987 and serves as director of the Meritus Health Center
for Total Joint Replacement.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PETLIFE PHARMACEUTICALS, INC.
(Registrant)
Dated: March 24, 2016
|
By:
|
/s/ Dr. Arthur Mikaelian
|
|
Dr. Arthur Mikaelian
|
|
President
|
Petlife Pharmaceuticals (CE) (USOTC:PTLF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Petlife Pharmaceuticals (CE) (USOTC:PTLF)
Historical Stock Chart
From Jul 2023 to Jul 2024